A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

NCT03261947 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Cancer
Colorectal Cancer
Esophageal Neoplasms
Carcinoma, Non-small-cell Lung

Interventions

DRUG: TAK-931

Sponsor

Millennium Pharmaceuticals, Inc.